These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22309877)

  • 21. Ovarian reserve.
    Coccia ME; Rizzello F
    Ann N Y Acad Sci; 2008 Apr; 1127():27-30. PubMed ID: 18443326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation?
    Čuš M; Vlaisavljević V; Repnik K; Potočnik U; Kovačič B
    J Assist Reprod Genet; 2019 Jan; 36(1):47-55. PubMed ID: 30406448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology.
    Alviggi C; Pettersson K; Longobardi S; Andersen CY; Conforti A; De Rosa P; Clarizia R; Strina I; Mollo A; De Placido G; Humaidan P
    Reprod Biol Endocrinol; 2013 Jun; 11():51. PubMed ID: 23725475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation.
    Riccetti L; De Pascali F; Gilioli L; Santi D; Brigante G; Simoni M; Casarini L
    Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():15-25. PubMed ID: 28506471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation.
    Jayaprakasan K; Deb S; Batcha M; Hopkisson J; Johnson I; Campbell B; Raine-Fenning N
    Fertil Steril; 2010 Oct; 94(5):1775-81. PubMed ID: 19931077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.
    Ganidou MA; Kolibianakis EM; Venetis CA; Gerou S; Makedos GA; Klearchou N; Tarlatzis BC
    Gynecol Endocrinol; 2014 Nov; 30(11):817-21. PubMed ID: 24989633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
    Scheffer JAB; Scheffer B; Scheffer R; Florencio F; Grynberg M; Lozano DM
    JBRA Assist Reprod; 2018 Sep; 22(3):215-220. PubMed ID: 29949322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
    Chan C; Liu K
    J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.
    Grisendi V; La Marca A
    Minerva Ginecol; 2017 Jun; 69(3):250-258. PubMed ID: 28271699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol.
    Li Y; Duan Y; Yuan X; Cai B; Xu Y; Yuan Y
    Front Endocrinol (Lausanne); 2021; 12():688654. PubMed ID: 34594300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).
    Fatemi H; Bilger W; Denis D; Griesinger G; La Marca A; Longobardi S; Mahony M; Yin X; D'Hooghe T
    Reprod Biol Endocrinol; 2021 May; 19(1):68. PubMed ID: 33975610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Protocols of Controlled Ovarian Stimulation in Obtaining Mature Oocytes (MII): Retrospective Study on Assisted Reproductive Technology Procedures.
    Martins CMRB; Ruivo PCPFGC; Vaz-Oliani DCM; Martins RAS; Oliani AH
    JBRA Assist Reprod; 2022 Aug; 26(3):387-397. PubMed ID: 34786902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FSH and folliculogenesis: from physiology to ovarian stimulation.
    Vegetti W; Alagna F
    Reprod Biomed Online; 2006 Jun; 12(6):684-94. PubMed ID: 16792843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis.
    Peluso C; Oliveira R; Laporta GZ; Christofolini DM; Fonseca FLA; Laganà AS; Barbosa CP; Bianco B
    Gynecol Endocrinol; 2021 Apr; 37(4):358-366. PubMed ID: 32613875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
    La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
    Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.